Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

Share Price is delayed by 15 minutes
Get Live Data
5,450.00    -50.00 (-0.91%)
Bid:
5,400.00
Ask:
5,450.00
Spread: 50.00 (0.926%)
Market Cap: £137.76m
CAM Live PriceLast checked at - London Stock Exchange

Intraday Camellia Share Chart

Value Enhancement Plan Date & Presentation

8 May 2025 07:00

RNS Number : 7651H
Camellia PLC
08 May 2025
Β 

8 May 2025

Camellia Plc

Confirmation of Value Enhancement Plan date & Investor presentation

Camellia is pleased to announce that details of its Value Enhancement Plan ('VEP'), focussed on improving operating results, growth areas, and capital allocation priorities, will be announced on Monday, 19 May 2025.

Camellia will host a live presentation via Investor Meet Company on Wednesday, 21 May 2025 at 10:00 BST to discuss its VEP. The presentation is open to all existing and potential shareholders, with the opportunity for live Q&A. Investors can sign up to Investor Meet Company for free at: https://www.investormeetcompany.com/camellia-plc/register-investor. Questions can be submitted ahead of the event via the Investor Meet Company dashboard up until Wednesday, 21 May 2025, 09:00 BST, or at any time during the presentation.

A recorded presentation on the VEP will also be on Camellia's website on Monday, 19 May 2025.

Β 

About Camellia

Camellia is the ultimate holding company of a portfolio of international businesses and assets, with its core operating companies focused on agriculture growing tea, avocado, macadamia and arable crops (the "Group"). The operating companies in the GroupΒ own andΒ manage 50,000 hectares across three continents.Β Camellia's objective is to invest sustainably for the long-term to deliver attractive returns to shareholders while operating in harmony with the environment and supporting local communities where the companies operate.

https://www.camellia.plc.uk/

Enquiries:

Camellia Plc 01622 746655Β 

Byron Coombs Chief Executive investorrelations@camellia.co.uk

Oliver Capon, Chief Financial OfficerΒ 

Panmure LiberumΒ (Nominated Adviser and Broker) 020 7886 2500Β 

Emma EarlΒ 

Rupert DeardenΒ 

H/Advisers MaitlandΒ (Financial PR) 07785 292617Β 

William Clutterbuck

Investors can register to receive updates and news from the Company by registering their email address at investorrelations@camellia.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCFLFLRERIDIIE
Date   Source Headline
4th Jun 202612:31 pmRNSResult of AGM
22nd May 20267:00 amRNSSale of Chalouni Tea Estate
5th May 20267:00 amRNSFinal Results
7th Apr 20264:19 pmRNSProposed Sale of Chalouni Tea Estate
1st Apr 20267:00 amRNSArtwork Sale and Update on Indian Tea Estate MOU
23rd Feb 20267:00 amRNSTrading Update
23rd Jan 20267:00 amRNSDirectorate change
27th Nov 20257:00 amRNSKakuzi Land Claims
8th Sep 20254:47 pmRNSDirector/PDMR Shareholding
5th Sep 20257:00 amRNSHalf Year Results
26th Aug 20257:00 amRNSNotice of Half Year Results
4th Jul 20254:30 pmRNSDisposal
13th Jun 20254:01 pmRNSHolding(s) in Company
13th Jun 20252:35 pmRNSHolding(s) in Company
10th Jun 20259:09 amRNSHolding(s) in Company
9th Jun 20254:39 pmRNSHolding(s) in Company 9 June 2025
6th Jun 20257:00 amRNSResult of Tender Offer
5th Jun 20252:02 pmRNSResult of General Meetings
19th May 20257:00 amRNSTender Offer
19th May 20257:00 amRNSValue Enhancement Plan
13th May 20257:00 amRNSHolding(s) in Company
9th May 20257:00 amRNSTransaction in Own Shares
8th May 20257:00 amRNSValue Enhancement Plan Date & Presentation
30th Apr 20257:00 amRNSFinal Results
28th Apr 20257:00 amRNSTransaction in Own Shares
25th Apr 20257:00 amRNSTransaction in Own Shares
24th Apr 20257:00 amRNSTransaction in Own Shares
23rd Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20257:00 amRNSTransaction in Own Shares
17th Apr 20257:00 amRNSPotential Disposal
15th Apr 20257:00 amRNSTransaction in Own Shares
14th Apr 20257:00 amRNSTransaction in Own Shares
9th Apr 20257:00 amRNSTransaction in Own Shares
8th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 20259:07 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSDisposal
11th Mar 20257:00 amRNSTransaction in Own Shares
5th Mar 20257:00 amRNSTransaction in Own Shares
4th Mar 20257:00 amRNSTransaction in Own Shares
26th Feb 20257:00 amRNSTransaction in Own Shares
25th Feb 20257:00 amRNSTransaction in Own Shares
20th Feb 20257:00 amRNSTransaction in Own Shares
17th Feb 20257:00 amRNSTransaction in Own Shares
12th Feb 20257:00 amRNSPotential Disposal
11th Feb 20257:00 amRNSTransaction in Own Shares
10th Feb 20257:00 amRNSTransaction in Own Shares
7th Feb 20257:00 amRNSTransaction in Own Shares
6th Feb 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.